240 related articles for article (PubMed ID: 28555079)
1. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.
Pyzer AR; Stroopinsky D; Rosenblatt J; Anastasiadou E; Rajabi H; Washington A; Tagde A; Chu JH; Coll M; Jiao AL; Tsai LT; Tenen DE; Cole L; Palmer K; Ephraim A; Leaf RK; Nahas M; Apel A; Bar-Natan M; Jain S; McMasters M; Mendez L; Arnason J; Raby BA; Slack F; Kufe D; Avigan D
Leukemia; 2017 Dec; 31(12):2780-2790. PubMed ID: 28555079
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
Bouillez A; Rajabi H; Jin C; Samur M; Tagde A; Alam M; Hiraki M; Maeda T; Hu X; Adeegbe D; Kharbanda S; Wong KK; Kufe D
Oncogene; 2017 Jul; 36(28):4037-4046. PubMed ID: 28288138
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.
Wang X; Li J; Dong K; Lin F; Long M; Ouyang Y; Wei J; Chen X; Weng Y; He T; Zhang H
Cell Signal; 2015 Mar; 27(3):443-52. PubMed ID: 25499621
[TBL] [Abstract][Full Text] [Related]
4. [Expression and Clinical Significance of PD-L1 and MicroRNA-138-5p in Patients with Acute Myeloid Leukemia].
Huang CY; Zha XF; Wen WR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):373-378. PubMed ID: 30998140
[TBL] [Abstract][Full Text] [Related]
5. MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
Maeda T; Hiraki M; Jin C; Rajabi H; Tagde A; Alam M; Bouillez A; Hu X; Suzuki Y; Miyo M; Hata T; Hinohara K; Kufe D
Cancer Res; 2018 Jan; 78(1):205-215. PubMed ID: 29263152
[TBL] [Abstract][Full Text] [Related]
6. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
[TBL] [Abstract][Full Text] [Related]
8. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
Tao Z; Xu S; Ruan H; Wang T; Song W; Qian L; Chen K
Cell Physiol Biochem; 2018; 48(2):801-814. PubMed ID: 30032144
[TBL] [Abstract][Full Text] [Related]
9. Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.
Sun C; Lan P; Han Q; Huang M; Zhang Z; Xu G; Song J; Wang J; Wei H; Zhang J; Sun R; Zhang C; Tian Z
Nat Commun; 2018 Mar; 9(1):1241. PubMed ID: 29593314
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma.
Liu Z; Wen J; Wu C; Hu C; Wang J; Bao Q; Wang H; Wang J; Zhou Q; Wei L; Shen Y; Zhang W
Aging (Albany NY); 2020 Jan; 12(2):1213-1236. PubMed ID: 31981455
[TBL] [Abstract][Full Text] [Related]
11. miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
Jia L; Xi Q; Wang H; Zhang Z; Liu H; Cheng Y; Guo X; Zhang J; Zhang Q; Zhang L; Xue Z; Li Y; Da Y; Zhao P; Zhang R
Biochem Biophys Res Commun; 2017 Jun; 488(2):425-431. PubMed ID: 28511795
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.
Wang Y; Wang D; Xie G; Yin Y; Zhao E; Tao K; Li R
Oncotarget; 2017 Apr; 8(17):28125-28134. PubMed ID: 28427226
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of PD-L1 by MicroRNA in Mismatch Repair Deficient-Colorectal Cancer].
Ashizawa M; Okayama H; Aung Kyi Thar Min ; Noda M; Aoto K; Nakajima T; Ishigame T; Mimura K; Kono K
Gan To Kagaku Ryoho; 2017 Oct; 44(10):889-891. PubMed ID: 29066686
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.
Ji X; Wang E; Tian F
Biochem Biophys Res Commun; 2018 Jan; 495(1):1342-1348. PubMed ID: 29170130
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
16. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer.
Mirili C; Paydas S; Kilic EB; Seydaoglu G; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M; Ergin M; Zorludemir S
J BUON; 2020; 25(1):159-167. PubMed ID: 32277627
[TBL] [Abstract][Full Text] [Related]
18. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed miR-195 attenuated immune escape of diffuse large B-cell lymphoma by targeting PD-L1.
He B; Yan F; Wu C
Biomed Pharmacother; 2018 Feb; 98():95-101. PubMed ID: 29247952
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
Zhao L; Yu H; Yi S; Peng X; Su P; Xiao Z; Liu R; Tang A; Li X; Liu F; Shen S
Oncotarget; 2016 Jul; 7(29):45370-45384. PubMed ID: 27248318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
